Drug shortages homepage
Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.
A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.
Below are the newest and most recently updated Shortage and Discontinuation reports.
Shortage Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| FLULAVAL TETRA | ID BIOMEDICAL CORPORATION OF QUEBEC | Actual shortage | 15MCG 15MCG 15MCG 15MCG | Updated Report | 2019-09-17 | 94139 |
| POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP | PFIZER CANADA ULC | Actual shortage | 149MG | Updated Report | 2019-09-17 | 78955 |
| MYLAN-SIMVASTATIN | MYLAN PHARMACEUTICALS ULC | Actual shortage | 80MG | Updated Report | 2019-09-17 | 17773 |
| MYLAN-SIMVASTATIN | MYLAN PHARMACEUTICALS ULC | Actual shortage | 40MG | Updated Report | 2019-09-17 | 17769 |
| MYLAN-SIMVASTATIN | MYLAN PHARMACEUTICALS ULC | Actual shortage | 20MG | Updated Report | 2019-09-17 | 51639 |
| MYLAN-SIMVASTATIN | MYLAN PHARMACEUTICALS ULC | Actual shortage | 10MG | Updated Report | 2019-09-17 | 51636 |
| MYLAN-SIMVASTATIN | MYLAN PHARMACEUTICALS ULC | Actual shortage | 5MG | Updated Report | 2019-09-17 | 38547 |
| CREON MINIMICROSPHERES 25 | BGP PHARMA ULC | Actual shortage | 25500UNIT 1600UNIT 25000UNIT | Updated Report | 2019-09-17 | 92740 |
| MAVIK | BGP PHARMA ULC | Anticipated shortage | 2MG | Updated Report | 2019-09-17 | 91626 |
| KADIAN | BGP PHARMA ULC | Anticipated shortage | 100MG | New Report | 2019-09-17 | 94104 |
| MAVIK | BGP PHARMA ULC | Actual shortage | 0.5MG | Updated Report | 2019-09-17 | 91623 |
| INDAYO | MYLAN PHARMACEUTICALS ULC | Anticipated shortage | 0.03MG 0.15MG | New Report | 2019-09-17 | 94099 |
| MYLAN-VERAPAMIL | MYLAN PHARMACEUTICALS ULC | Actual shortage | 120MG | Updated Report | 2019-09-17 | 88302 |
| MYLAN-VERAPAMIL SR | MYLAN PHARMACEUTICALS ULC | Actual shortage | 120MG | Updated Report | 2019-09-17 | 91047 |
| MYLAN-VERAPAMIL | MYLAN PHARMACEUTICALS ULC | Actual shortage | 80MG | Updated Report | 2019-09-17 | 80452 |
| MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL | MYLAN PHARMACEUTICALS ULC | Actual shortage | 300MG 200MG | Updated Report | 2019-09-17 | 90113 |
| MOVISSE | MYLAN PHARMACEUTICALS ULC | Actual shortage | 0.35MG | Updated Report | 2019-09-17 | 91044 |
| MYLAN-HYDROXYUREA | MYLAN PHARMACEUTICALS ULC | Actual shortage | 500MG | Updated Report | 2019-09-17 | 72303 |
| MYLAN-ATAZANAVIR | MYLAN PHARMACEUTICALS ULC | Actual shortage | 200MG | Updated Report | 2019-09-17 | 76489 |
| RANITIDINE | SIVEM PHARMACEUTICALS ULC | Anticipated shortage | 300MG | New Report | 2019-09-17 | 94081 |
| RANITIDINE | SIVEM PHARMACEUTICALS ULC | Anticipated shortage | 150MG | New Report | 2019-09-17 | 94078 |
| POTASSIUM CHLORIDE INJECTION | BAXTER CORPORATION | Actual shortage | 7.46MG | Updated Report | 2019-09-17 | 89426 |
| PMS-VENLAFAXINE XR | PHARMASCIENCE INC | Actual shortage | 37.5MG | New Report | 2019-09-17 | 94073 |
| CYCLOMEN | SANOFI-AVENTIS CANADA INC | Actual shortage | 50MG | Updated Report | 2019-09-17 | 58113 |
| CYCLOMEN | SANOFI-AVENTIS CANADA INC | Actual shortage | 100MG | Updated Report | 2019-09-17 | 87756 |
| CYCLOMEN | SANOFI-AVENTIS CANADA INC | Actual shortage | 200MG | Updated Report | 2019-09-17 | 76396 |
| MYLAN-MINOCYCLINE | MYLAN PHARMACEUTICALS ULC | Actual shortage | 100MG | Updated Report | 2019-09-17 | 5919 |
| MYLAN-MINOCYCLINE | MYLAN PHARMACEUTICALS ULC | Actual shortage | 100MG | Updated Report | 2019-09-17 | 7046 |
| MYLAN-MINOCYCLINE | MYLAN PHARMACEUTICALS ULC | Actual shortage | 50MG | Updated Report | 2019-09-17 | 7049 |
| MYLAN-BUPRENORPHINE/NALOXONE | MYLAN PHARMACEUTICALS ULC | Actual shortage | 8MG 2MG | Updated Report | 2019-09-17 | 3089 |
| MYLAN-BUPRENORPHINE/NALOXONE | MYLAN PHARMACEUTICALS ULC | Actual shortage | 2MG 0.5MG | Updated Report | 2019-09-17 | 7392 |
| SOLU-MEDROL | PFIZER CANADA ULC | Resolved | 40MG | Updated Report | 2019-09-17 | 93117 |
| ZYMAR | ALLERGAN INC | Actual shortage | 0.3% | Updated Report | 2019-09-17 | 33440 |
| ZYCLARA | VALEANT CANADA LP/VALEANT CANADA S.E.C. | Actual shortage | 3.75% | Updated Report | 2019-09-17 | 89896 |
| TAZORAC | ALLERGAN INC | Actual shortage | 0.05% | Updated Report | 2019-09-17 | 93944 |
| TAZORAC | ALLERGAN INC | Actual shortage | 0.1% | Updated Report | 2019-09-17 | 93947 |
| QUETIAPINE | SIVEM PHARMACEUTICALS ULC | Actual shortage | 25MG | Updated Report | 2019-09-17 | 93973 |
| RANITIDINE | SANIS HEALTH INC | Actual shortage | 300MG | Updated Report | 2019-09-17 | 93981 |
| RANITIDINE | SANIS HEALTH INC | Actual shortage | 150MG | Updated Report | 2019-09-17 | 93986 |
| OMNISCAN | GE HEALTHCARE CANADA INC | Resolved | 287MG | Updated Report | 2019-09-17 | 93472 |
| GLUMETZA | VALEANT CANADA LP/VALEANT CANADA S.E.C. | Actual shortage | 1000MG | Updated Report | 2019-09-17 | 93535 |
| PMS-RABEPRAZOLE EC | PHARMASCIENCE INC | Actual shortage | 20MG | Updated Report | 2019-09-17 | 93831 |
| PMS-TESTOSTERONE | PHARMASCIENCE INC | Actual shortage | 40MG | Updated Report | 2019-09-17 | 93837 |
| GENOTROPIN | PFIZER CANADA ULC | Actual shortage | 1.4MG | Updated Report | 2019-09-17 | 93856 |
| MUSE | PALADIN LABS INC | Actual shortage | 250MCG | Updated Report | 2019-09-17 | 93978 |
| BREVIBLOC PREMIXED INJECTION | BAXTER CORPORATION | Resolved | 10MG | Updated Report | 2019-09-17 | 91707 |
| APO-QUINAPRIL/HCTZ | APOTEX INC | Actual shortage | 12.5MG 10MG | Updated Report | 2019-09-16 | 91103 |
| APO-QUINAPRIL/HCTZ | APOTEX INC | Actual shortage | 25MG 20MG | Updated Report | 2019-09-16 | 89167 |
| APO-CAPTO TAB 25MG | APOTEX INC | Resolved | 25MG | Updated Report | 2019-09-16 | 89510 |
| APO-VENLAFAXINE XR | APOTEX INC | Actual shortage | 75.0MG | Updated Report | 2019-09-16 | 89557 |
Discontinuation Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| MYLAN-SIMVASTATIN | MYLAN PHARMACEUTICALS ULC | To be discontinued | 80MG | New Report | 2019-09-17 | 94132 |
| MYLAN-SIMVASTATIN | MYLAN PHARMACEUTICALS ULC | To be discontinued | 40MG | New Report | 2019-09-17 | 94127 |
| MYLAN-SIMVASTATIN | MYLAN PHARMACEUTICALS ULC | To be discontinued | 20MG | New Report | 2019-09-17 | 94122 |
| MYLAN-SIMVASTATIN | MYLAN PHARMACEUTICALS ULC | To be discontinued | 10MG | New Report | 2019-09-17 | 94117 |
| MYLAN-SIMVASTATIN | MYLAN PHARMACEUTICALS ULC | To be discontinued | 5MG | New Report | 2019-09-17 | 94112 |
